Non-invasive Buttock Lifting Induced by Magnetic Device - Multicentric Study

Sponsor
BTL Industries Ltd. (Industry)
Overall Status
Withdrawn
CT.gov ID
NCT03579147
Collaborator
(none)
0
7
1
21.5
0
0

Study Details

Study Description

Brief Summary

This study will evaluate the clinical safety and patient satisfaction with the high power magnet system for the aesthetic improvement of buttocks. The study is a prospective multi-center open-label single-arm study. The subjects will be enrolled and assigned into a single study group. Subjects will be required to complete four (4) treatment visits and three follow-up visits - 1 month, 3 months and 12 months after the final treatment. Study will be conducted at several study sites.

At the baseline visit, subject's weight will be recorded. Subjects will receive Buttocks Evaluation Questionnaire to fill in.

The treatment administration phase will consist of four (4) treatments, delivered twice a week. The applicator will be applied over the gluteal area. Visible contractions will be induced by the device.

At the last therapy visit, the subject's weight will be recorded. In addition, subjects will receive Subject Satisfaction, Buttocks Evaluation and Therapy Comfort Questionnaires to fill in.

Safety measures will include documentation of adverse events (AE) including subject's experience of pain or discomfort after the procedure. Following each treatment administration and at the follow-up visits, subjects will be checked for immediate post-procedure adverse event assessment.

Post-procedure evaluation (follow-up visits) will be conducted 1 month, 3 months and 12 months after the final treatment. A weight measure will be conducted. Also, subject's satisfaction and buttocks evaluation will be noted.

Condition or Disease Intervention/Treatment Phase
  • Device: Treatment with BTL EMSCULPT device
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Safety and Patient Satisfaction With Noninvasive Repetitive Pulse Magnetic Stimulation (rPMS) for Aesthetic Improvements of Buttocks
Actual Study Start Date :
Dec 15, 2017
Anticipated Primary Completion Date :
May 30, 2019
Anticipated Study Completion Date :
Sep 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treatment Group

Treatment with the investigational device BTL EMSCULPT.

Device: Treatment with BTL EMSCULPT device
The treatment administration phase will consist of four (4) treatments, delivered twice a week. The applicator will be applied over the buttock area. Visible contractions will be induced by the device.

Outcome Measures

Primary Outcome Measures

  1. Subject's satisfaction [13 months]

    The 5-point Likert scale Subject Satisfaction Questionnaire will be used for an analysis of the subject's opinion of the therapy results. Subjects will be evaluating agreement with three different statements (concerning satisfaction with therapy results and appearance of abdominal area after therapy) by choosing an answer on a scale between 1 (Strongly disagree) and 5 (Strongly agree). Minimally 80% of the treated subjects should report the agreement with all three statements given in the questionnaire (answers "Agree" and "Strongly agree") in order to claim subject's satisfaction with the therapy outcome.

  2. Effectiveness of the device assessed through Buttocks Evaluation Questionnaire [13 months]

    The 7 point Likert scale Buttocks Evaluation Questionnaire will be used for an assessment if there is a change in subject's perception of their own buttocks area before and after the therapy session. The total possible score ranges from 4 points (lowest possible satisfaction) to 28 points (highest possible satisfaction).

Secondary Outcome Measures

  1. Occurrence of treatment-related adverse events [13 months]

    The secondary objective of the study is to determine side effects and adverse events (AE) associated with the treatment of the abdominal area. The occurrence of adverse events will be followed throughout the whole study.

  2. Therapy comfort [3 months]

    Therapy comfort will be noted at the last therapy visit. Subjects will be asked to evaluate the agreement with the statement concerning the conformity of the study treatment. Subjects will be evaluating the agreement by choosing an answer on a scale between 1 (Strongly disagree) and 5 (Strongly agree). Based on a given answers, the therapy comfort will be calculated.

Eligibility Criteria

Criteria

Ages Eligible for Study:
22 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Voluntarily signed informed consent form

  • BMI ≤ 30 kg/m2

  • Women of child-bearing potential are required to use birth control measures during the

  • whole duration of the study

  • Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring during study participation

  • Subjects willing and able to maintain his/her regular (pre-procedure) diet and exercise regimen without effecting significant change in either direction during study participation

Exclusion Criteria:
  • Cardiac pacemakers

  • Electronic implants

  • Pulmonary insufficiency

  • Metal implants

  • Drug pumps

  • Haemorrhagic conditions

  • Anticoagulation therapy

  • Heart disorders

  • Malignant tumor

  • Fever

  • Pregnancy

  • Breastfeeding

  • Following recent surgical procedures when muscle contraction may disrupt the healing process

  • Application over menstruating uterus

  • Application over areas of the skin which lack normal sensation

  • Scars, open lesions and wounds at the treatment area

  • Unrepaired abdominal hernia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Contour Medical Gilbert Arizona United States 85297
2 Plastic Surgery Excellence Beverly Hills California United States 90212
3 Dr. Mariano Busso Aesthetic Dermatology Miami Florida United States 33133
4 Chicago Cosmetic Surgery and Dermatology Chicago Illinois United States 60654
5 Ovation Med Spa Houston Texas United States 77056
6 Refresh Dermatology Houston Texas United States 77401
7 Aesthe Clinic Sofia Bulgaria 1000

Sponsors and Collaborators

  • BTL Industries Ltd.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
BTL Industries Ltd.
ClinicalTrials.gov Identifier:
NCT03579147
Other Study ID Numbers:
  • BTL-Buttocks_001
First Posted:
Jul 6, 2018
Last Update Posted:
May 26, 2020
Last Verified:
May 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes

Study Results

No Results Posted as of May 26, 2020